JP2021504430A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504430A5 JP2021504430A5 JP2020529611A JP2020529611A JP2021504430A5 JP 2021504430 A5 JP2021504430 A5 JP 2021504430A5 JP 2020529611 A JP2020529611 A JP 2020529611A JP 2020529611 A JP2020529611 A JP 2020529611A JP 2021504430 A5 JP2021504430 A5 JP 2021504430A5
- Authority
- JP
- Japan
- Prior art keywords
- drug conjugate
- antibody
- antibody drug
- seq
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762593807P | 2017-12-01 | 2017-12-01 | |
| US62/593,807 | 2017-12-01 | ||
| US201762595045P | 2017-12-05 | 2017-12-05 | |
| US62/595,045 | 2017-12-05 | ||
| PCT/IB2018/059480 WO2019106608A1 (en) | 2017-12-01 | 2018-11-29 | Anti-cd40 antibody drug conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021504430A JP2021504430A (ja) | 2021-02-15 |
| JP2021504430A5 true JP2021504430A5 (enExample) | 2022-01-06 |
Family
ID=66663861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529611A Ceased JP2021504430A (ja) | 2017-12-01 | 2018-11-29 | 抗ｃｄ４０抗体薬物コンジュゲート |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220265842A1 (enExample) |
| EP (1) | EP3716982A4 (enExample) |
| JP (1) | JP2021504430A (enExample) |
| KR (1) | KR20200095493A (enExample) |
| CN (1) | CN111465399A (enExample) |
| AU (1) | AU2018374633A1 (enExample) |
| BR (1) | BR112020010691A2 (enExample) |
| CA (1) | CA3081559A1 (enExample) |
| CL (1) | CL2020001442A1 (enExample) |
| CR (1) | CR20200285A (enExample) |
| DO (1) | DOP2020000119A (enExample) |
| EC (1) | ECSP20034868A (enExample) |
| IL (1) | IL274650A (enExample) |
| MX (1) | MX2020005465A (enExample) |
| PE (1) | PE20201464A1 (enExample) |
| PH (1) | PH12020550551A1 (enExample) |
| RU (1) | RU2020117156A (enExample) |
| SG (1) | SG11202004865SA (enExample) |
| WO (1) | WO2019106608A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3125886A1 (en) * | 2019-01-11 | 2020-07-16 | Novartis Ag | Anti-cd40 antibodies for use in treatment of hidradenitis suppurativa |
| CA3203533A1 (en) * | 2021-01-07 | 2022-07-14 | Jay ROTHSTEIN | Novel steroid payloads, steroid linkers, adcs containing and use thereof |
| JP2024506012A (ja) * | 2021-02-04 | 2024-02-08 | 上海森▲輝▼医▲葯▼有限公司 | グルココルチコイド受容体アゴニストの薬物複合体及びその医薬的応用 |
| CN117043172A (zh) * | 2021-03-23 | 2023-11-10 | 伊莱利利公司 | 糖皮质激素受体激动剂 |
| AR125079A1 (es) * | 2021-03-23 | 2023-06-07 | Lilly Co Eli | Agonistas de receptores de glucocorticoides sustituidos con carboxi |
| AR125084A1 (es) | 2021-03-23 | 2023-06-07 | Lilly Co Eli | Agonistas del receptor de glucocorticoides novedosos |
| TWI899455B (zh) * | 2021-03-23 | 2025-10-01 | 美商美國禮來大藥廠 | 糖皮質素受體激動劑 |
| CN117580849A (zh) * | 2021-06-24 | 2024-02-20 | 江苏先声药业有限公司 | 甾体类化合物、其药物组合物及其应用 |
| CN120463762A (zh) * | 2021-08-26 | 2025-08-12 | 映恩生物科技(上海)有限公司 | 一种甾体化合物及其缀合物 |
| US20250179114A1 (en) * | 2021-09-14 | 2025-06-05 | Duality Biologics (Suzhou) Co., Ltd. | Anti-Inflammatory Compound and Use Thereof |
| WO2023245106A1 (en) | 2022-06-16 | 2023-12-21 | Abbvie Biotherapeutics Inc. | Anti-cd19 antibody drug conjugates |
| CN120239705A (zh) | 2022-07-21 | 2025-07-01 | 萤火虫生物股份有限公司 | 糖皮质激素受体激动剂和其缀合物 |
| AU2023347987A1 (en) * | 2022-09-22 | 2025-04-10 | Eli Lilly And Company | Glucocorticoid receptor agonists |
| EP4643877A1 (en) * | 2022-12-28 | 2025-11-05 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Composition of cd40-binding molecule and pharmaceutical use thereof |
| TW202430226A (zh) * | 2022-12-28 | 2024-08-01 | 大陸商上海盛迪醫藥有限公司 | 抗cd40抗體藥物偶聯物、其製備方法及其醫藥用途 |
| WO2026035986A1 (en) | 2024-08-07 | 2026-02-12 | Bighat Biosciences, Inc. | Humanized anti-cdh17 antibodies and use of the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101878221B (zh) * | 2007-11-30 | 2014-04-02 | 辉瑞有限公司 | 糖皮质激素受体激动剂 |
| TW200944540A (en) * | 2007-12-21 | 2009-11-01 | Schering Corp | C20-C21 substituted glucocorticoid receptor agonists |
| WO2012149356A2 (en) * | 2011-04-29 | 2012-11-01 | Apexigen, Inc. | Anti-cd40 antibodies and methods of use |
| GB201309807D0 (en) * | 2013-05-31 | 2013-07-17 | Pharma Mar Sau | Antibody drug conjugates |
| WO2015153401A1 (en) * | 2014-04-04 | 2015-10-08 | Merck Sharp & Dohme Corp | Phosphate based linkers for intracellular delivery of drug conjugates |
| RU2715597C2 (ru) * | 2015-05-29 | 2020-03-02 | Эббви Инк. | Антитела к cd40 и способы их применения |
| SG10202001787QA (en) * | 2016-06-02 | 2020-04-29 | Abbvie Inc | Glucocorticoid receptor agonist and immunoconjugates thereof |
-
2018
- 2018-11-29 JP JP2020529611A patent/JP2021504430A/ja not_active Ceased
- 2018-11-29 CN CN201880077793.3A patent/CN111465399A/zh active Pending
- 2018-11-29 BR BR112020010691-7A patent/BR112020010691A2/pt not_active Application Discontinuation
- 2018-11-29 US US16/768,616 patent/US20220265842A1/en not_active Abandoned
- 2018-11-29 SG SG11202004865SA patent/SG11202004865SA/en unknown
- 2018-11-29 MX MX2020005465A patent/MX2020005465A/es unknown
- 2018-11-29 AU AU2018374633A patent/AU2018374633A1/en not_active Abandoned
- 2018-11-29 CA CA3081559A patent/CA3081559A1/en active Pending
- 2018-11-29 WO PCT/IB2018/059480 patent/WO2019106608A1/en not_active Ceased
- 2018-11-29 RU RU2020117156A patent/RU2020117156A/ru unknown
- 2018-11-29 CR CR20200285A patent/CR20200285A/es unknown
- 2018-11-29 PE PE2020000592A patent/PE20201464A1/es unknown
- 2018-11-29 EP EP18883152.3A patent/EP3716982A4/en not_active Withdrawn
- 2018-11-29 KR KR1020207017805A patent/KR20200095493A/ko active Pending
-
2020
- 2020-05-04 PH PH12020550551A patent/PH12020550551A1/en unknown
- 2020-05-13 IL IL274650A patent/IL274650A/en unknown
- 2020-05-29 CL CL2020001442A patent/CL2020001442A1/es unknown
- 2020-06-15 DO DO2020000119A patent/DOP2020000119A/es unknown
- 2020-06-29 EC ECSENADI202034868A patent/ECSP20034868A/es unknown